• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性蛋白A在体外可降低人肺泡巨噬细胞对卡氏肺孢子虫的黏附和吞噬作用。

Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro.

作者信息

Koziel H, Phelps D S, Fishman J A, Armstrong M Y, Richards F F, Rose R M

机构信息

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Am J Respir Cell Mol Biol. 1998 Jun;18(6):834-43. doi: 10.1165/ajrcmb.18.6.3059.

DOI:10.1165/ajrcmb.18.6.3059
PMID:9618388
Abstract

Surfactant protein-A (SP-A) levels are increased in Pneumocystis carinii pneumonia, but the role of SP-A in the pathogenesis of P. carinii pneumonia is not completely understood. This study investigated the effect of SP-A on the in vitro binding and phagocytosis of P. carinii by normal human alveolar macrophages (AM). Determination of binding and phagocytosis was done with a fluorescence-based assay, utilizing fluorescein isothiocyanate (FITC)-labeled P. carinii. Binding and phagocytosis of P. carinii to AM correlated inversely with the levels of SP-A present on the surface of the organisms (r = -0.6323, P = 0.0086; and r = -0.9827, P < 0.0001, respectively). The addition of exogenous SP-A to organisms with low surface-associated SP-A reduced P. carinii binding by 30% (P < 0.05) and reduced phagocytosis by 20% (P < 0.05), whereas this effect was reversed with ethylenediamine tetraacetic acid (EDTA) or anti-SP-A antibody. Furthermore, binding and phagocytosis were enhanced after enzymatic removal of P. carinii surface-associated SP-A, and this effect was reversed with the addition of exogenous SP-A. The observed inhibitory effect of SP-A on P. carinii binding and phagocytosis reflected binding of SP-A to the organisms rather than a direct effect of SP-A on the macrophages. These data suggest that increased levels of SP-A may contribute to the pathogenesis of P. carinii pneumonia through binding to the surface of the organism and interfering with AM recognition of this opportunistic pulmonary pathogen.

摘要

卡氏肺孢子虫肺炎患者的表面活性蛋白A(SP-A)水平升高,但SP-A在卡氏肺孢子虫肺炎发病机制中的作用尚未完全明确。本研究调查了SP-A对正常人肺泡巨噬细胞(AM)体外结合和吞噬卡氏肺孢子虫的影响。采用基于荧光的检测方法,利用异硫氰酸荧光素(FITC)标记的卡氏肺孢子虫来测定结合和吞噬情况。卡氏肺孢子虫与AM的结合及吞噬与生物体表面存在的SP-A水平呈负相关(r分别为-0.6323,P = 0.0086;以及r = -0.9827,P < 0.0001)。向表面相关SP-A水平低的生物体添加外源性SP-A可使卡氏肺孢子虫的结合减少30%(P < 0.05),吞噬减少20%(P < 0.05),而乙二胺四乙酸(EDTA)或抗SP-A抗体可逆转这种作用。此外,酶法去除卡氏肺孢子虫表面相关的SP-A后,结合和吞噬增强,添加外源性SP-A可逆转这种作用。观察到的SP-A对卡氏肺孢子虫结合和吞噬的抑制作用反映了SP-A与生物体的结合,而非SP-A对巨噬细胞的直接作用。这些数据表明,SP-A水平升高可能通过与生物体表面结合并干扰AM对这种机会性肺部病原体的识别,从而促进卡氏肺孢子虫肺炎的发病机制。

相似文献

1
Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro.表面活性蛋白A在体外可降低人肺泡巨噬细胞对卡氏肺孢子虫的黏附和吞噬作用。
Am J Respir Cell Mol Biol. 1998 Jun;18(6):834-43. doi: 10.1165/ajrcmb.18.6.3059.
2
Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.人表面活性蛋白A增强卡氏肺孢子虫与大鼠肺泡巨噬细胞的黏附。
Am J Respir Cell Mol Biol. 1996 Mar;14(3):232-8. doi: 10.1165/ajrcmb.14.3.8845173.
3
Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages.硝化的表面活性蛋白A不会增强卡氏肺孢子虫对肺泡巨噬细胞的黏附。
Am J Physiol. 1998 Dec;275(6):L1031-9. doi: 10.1152/ajplung.1998.275.6.L1031.
4
Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages.表面活性蛋白A而非表面活性蛋白D是大鼠肺泡巨噬细胞吞噬甲型流感病毒的调理素。
Eur J Immunol. 1997 Apr;27(4):886-90. doi: 10.1002/eji.1830270413.
5
The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii.表面活性蛋白A的碳水化合物识别结构域介导与卡氏肺孢子虫主要表面糖蛋白的结合。
Biochemistry. 1997 Jul 1;36(26):8092-9. doi: 10.1021/bi970313f.
6
Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.免疫抑制且缺乏表面活性蛋白A的小鼠对卡氏肺孢子虫感染的易感性增加。
J Infect Dis. 2001 Mar 15;183(6):943-52. doi: 10.1086/319252. Epub 2001 Feb 15.
7
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.卡氏肺孢子虫的120-kD表面糖蛋白是表面活性蛋白A的配体。
J Clin Invest. 1992 Jan;89(1):143-9. doi: 10.1172/JCI115554.
8
Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.卡氏肺孢子虫肺炎会改变肺凝集素SP-A和SP-D的表达及分布。
J Lab Clin Med. 2001 Jun;137(6):429-39. doi: 10.1067/mlc.2001.115220.
9
Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages.表面活性蛋白A对大鼠肺泡巨噬细胞中干扰素-γ和脂多糖诱导的亚硝酸盐生成具有不同的调节作用。
Am J Respir Cell Mol Biol. 2000 Dec;23(6):772-9. doi: 10.1165/ajrcmb.23.6.4083.
10
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.表面活性蛋白D与卡氏肺孢子菌相互作用,并介导该病原体黏附于肺泡巨噬细胞。
J Clin Invest. 1995 Jun;95(6):2699-710. doi: 10.1172/JCI117972.

引用本文的文献

1
Surfactant Protein A Can Affect Macrophage Phagocytosis: An Important Pathogenic Mechanism of Otitis Media with Effusion.表面活性蛋白 A 可影响巨噬细胞吞噬作用:分泌性中耳炎的一个重要致病机制。
J Assoc Res Otolaryngol. 2023 Apr;24(2):171-180. doi: 10.1007/s10162-023-00893-3. Epub 2023 Feb 23.
2
Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Innate Immunity.碳水化合物识别与 C 型凝集素受体在固有免疫中的研究现状
Front Immunol. 2021 Dec 16;12:798214. doi: 10.3389/fimmu.2021.798214. eCollection 2021.
3
Immune Response in Infections According to the Host Immune System Status.
根据宿主免疫系统状态的感染中的免疫反应
J Fungi (Basel). 2021 Jul 31;7(8):625. doi: 10.3390/jof7080625.
4
Collectins: Innate Immune Pattern Recognition Molecules.凝集素:先天免疫模式识别分子。
Adv Exp Med Biol. 2020;1204:75-127. doi: 10.1007/978-981-15-1580-4_4.
5
The Interaction of Human Pathogenic Fungi With C-Type Lectin Receptors.人类致病真菌与C型凝集素受体的相互作用
Front Immunol. 2018 Jun 4;9:1261. doi: 10.3389/fimmu.2018.01261. eCollection 2018.
6
Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?嗜酸粒细胞相关肺部疾病。表面活性蛋白 A 和 D 的帮助呼之欲出?
Am J Respir Cell Mol Biol. 2014 Nov;51(5):604-14. doi: 10.1165/rcmb.2014-0095TR.
7
HIV-1 Nef impairs key functional activities in human macrophages through CD36 downregulation.HIV-1 Nef 通过下调 CD36 损害人巨噬细胞中的关键功能活性。
PLoS One. 2014 Apr 4;9(4):e93699. doi: 10.1371/journal.pone.0093699. eCollection 2014.
8
An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.深入了解表面活性剂蛋白 A 和 D 在先天和适应性免疫中的多种作用。
Front Immunol. 2012 Jun 7;3:131. doi: 10.3389/fimmu.2012.00131. eCollection 2012.
9
Current understanding of Pneumocystis immunology.目前对肺孢子菌免疫学的认识。
Future Microbiol. 2010 Jan;5(1):43-65. doi: 10.2217/fmb.09.116.
10
Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.表面活性蛋白A对小鼠感染不同阶段鼠肺孢子菌与其宿主相互作用的影响。
J Eukaryot Microbiol. 2009 Jan-Feb;56(1):58-65. doi: 10.1111/j.1550-7408.2008.00363.x.